Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reproductive toxicology guidelines: comparison and application

D Beltrame1, G Mazué

  • 1Farmitalia Carlo Erba, Nerviano (Milan), Italy.

Annali Dell'Istituto Superiore Di Sanita
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anthracyclines - a review of general and special toxicity studies.

International journal of oncology·2011
Same author

Anthracyclines.

International journal of oncology·2011
Same author

Large-scale ultrasonic cleaning system: Design of a multi-transducer device for boat cleaning (20kHz).

Ultrasonics sonochemistry·2010
Same author

[Patient dissatisfaction with postoperative pain: what are the main reasons?].

Annales francaises d'anesthesie et de reanimation·2009
Same author

[Occupational exposure and chronic heart failure severity].

Giornale italiano di medicina del lavoro ed ergonomia·2008
Same author

Reproductive toxicity of exemestane, an antitumoral aromatase inactivator, in rats and rabbits.

Reproductive toxicology (Elmsford, N.Y.)·2001

Regulatory guidelines for reproductive toxicity studies vary, hindering global drug approval. Harmonizing these recommendations, especially for rodents, is crucial for international drug safety evaluation and requires greater flexibility.

Area of Science:

  • Pharmacology and Toxicology
  • Reproductive Toxicology
  • Drug Safety Evaluation

Background:

  • Current reproductive toxicity study guidelines from FDA, CPMP, and MHW share similar objectives but differ significantly.
  • These differences, particularly in rodent studies concerning treatment periods and progeny evaluation, impede mutual acceptance of data.
  • Existing guidelines present challenges in harmonizing experimental designs for global regulatory compliance.

Purpose of the Study:

  • To analyze and compare international regulatory guidelines for reproductive toxicity testing.
  • To identify specific differences and obstacles to mutual acceptance of study designs.
  • To advocate for harmonization and increased flexibility in regulatory requirements.

Main Methods:

  • Comparative analysis of reproductive toxicity study guidelines from major regulatory agencies (FDA, CPMP, MHW).

Related Experiment Videos

  • Evaluation of specific differences in rodent study designs, focusing on treatment duration and progeny assessment.
  • Discussion of advantages and disadvantages of differing approaches in relation to practical application.

    • Main Results:

    • Significant discrepancies exist between Western and Japanese recommendations, notably in pregnancy treatment periods and progeny studies.
    • Shortcomings, ambiguities, and valuable directives were identified within current regulatory instructions.
    • Conventional study designs are often inadequate or inapplicable for drugs with specific pharmacological activities or therapeutic uses.

    Conclusions:

    • International harmonization of reproductive toxicity testing guidelines is essential for efficient drug development and approval.
    • Greater flexibility and explicit policies are needed, particularly for specialized drug classes like antitumor agents.
    • Regulatory authorities should provide coordinated, detailed guidelines to address the complexities of modern drug evaluation.